Markman Advisors
Patent Valuation, Monetization and Investments

Blog

Markman Advisors Patent Blog

by Zachary Silbersher

Posts tagged equitable estoppel
Will “method-of-use thickets” grow from SCOTUS denial of the GSK v. Teva skinny label case?

Bad facts make bad law.  The case of GlaxoSmithKline’s lawsuit over Teva’s generic Coreg® drug is a case-in-point.  I previously blogged about the case here and here.  Given that the Supreme Court declined to grant certiorari, we’re now stuck with Federal Circuit precedent holding that a generic can still face liability for induced infringement of a method-of-use patent covering a section viii carved-out indication.  What will be the consequences of this?

Read More
Markman AdvisorsZachary Silbersher, Silbersher, Teva, GlaxoSmithKline, GSK, Takeda, Apotex, Warner-Lambert, skinny, skinny label, section viii, carve out, induced infringement, generic, brand, Orange Book, equitable estoppel, patent, Federal Circuit, en banc, Mylan, AlvotechComment